Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine.
Müller
Lars
L
Department of Pediatric Hematology and Oncology, University Medical Center, Heinrich-Heine-University, Düsseldorf, Germany.
Kramm
Christof M
CM
Tenenbaum
Tobias
T
Wessalowski
Rüdiger
R
Göbel
Ulrich
U
D001763:Blepharoptosis / Q000139:chemically induced* / Q000188:drug therapy*; D002675:Child, Preschool; D018572:Disease-Free Survival; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011729:Pyridostigmine Bromide / Q000008:administration & dosage / Q000627:therapeutic use*; D011736:Pyridoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D014750:Vincristine / Q000009:adverse effects*
D014750:Vincristine; D011736:Pyridoxine; D011729:Pyridostigmine Bromide